Personalized viral-based prime/boost immunotherapy targeting patient-specific or shared neoantigens: Immunogenicity, safety, and efficacy results from two ongoing phase I studies Meeting Abstract
| Authors: | Drake, C. G.; Johnson, M. L.; Spira, A. I.; Manji, G. A.; Carbone, D. P.; Henick, B. S.; Ingham, M.; Liao, C. Y.; Roychowdhury, S.; Kyi, C.; Basciano, P. A.; Bournazou, E.; Abhyankar, J.; Bezawada, A.; Kounavouth, S.; Schenk, D.; Ferguson, A. R.; Rousseau, R. F.; Catenacci, D. V. T. |
| Abstract Title: | Personalized viral-based prime/boost immunotherapy targeting patient-specific or shared neoantigens: Immunogenicity, safety, and efficacy results from two ongoing phase I studies |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 155s |
| Language: | English |
| ACCESSION: | WOS:000560368301388 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.3137 |
| Notes: | Meeting Abstract: 3137 -- Source: Wos |
